Experiment summary for ENCSR113CMI
doi:10.17989/ENCSR113CMI
Summary
- Status
- released
- Assay
- ChIP-seq (Control ChIP-seq)
- Control type
- input library
- Biosample summary
- Homo sapiens foreskin keratinocyte male newborn (2-4 days) treated with 1.2 mM calcium for 2.5 days
- Biosample Type
- primary cell
- Replication type
- anisogenic
- Description
- ChIP-seq control (input DNA) on primary keratinocytes in day 3 of differentiation
- Treatments
- 1.2 mM calcium (CHEBI:86158) for 2.5 days
- Nucleic acid type
- DNA
- RNA integrity number
- 8.5 [2-1]9 [1-1]
- Platform
- Illumina HiSeq 4000
Attribution
Genomics of Gene Regulation Project
- Lab
- Michael Snyder, Stanford
- Award
- U01HG007919 (Michael Snyder, Stanford)
- Project
- GGR
- External resources
- Aliases
- michael-snyder:ggr-skin-chipseq-control-day3-1
- Date submitted
- December 9, 2016
- Date released
- October 10, 2017
- Treatment Time Series
- ENCSR425GIF , ENCSR171FYM , ENCSR620NNW
Anisogenic replicates
Anisogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 2 | 1 | Homo sapiens male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 2.5 days | ENCBS299ONK | ENCLB713KCH |
| 1 | 1 | Homo sapiens male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 2.5 days | ENCBS079LRU | ENCLB429BHX |